Apogee Therapeutics to Participate in Upcoming March Investor Conferences

Company Overview - Apogee Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel biologics for inflammatory and immunology markets, including treatments for atopic dermatitis, asthma, chronic obstructive pulmonary disease, and eosinophilic esophagitis [3] - The company's lead program, APG777, targets atopic dermatitis, which is identified as the largest and least penetrated market in the inflammatory and immunology sector [3] - Apogee aims to achieve best-in-class efficacy and dosing through its antibody programs, which are designed to overcome limitations of existing therapies by utilizing advanced antibody engineering [3] Upcoming Events - Apogee Therapeutics will participate in the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 2:30 p.m. ET [2] - The company will also be present at the Leerink Global Healthcare Conference on March 11, 2025, at 8:40 a.m. ET [2] - A live and archived webcast of these events will be available on the company's website [2]